• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肾素-血管紧张素-醛固酮系统的活性及其对肺结核患者慢性心力衰竭治疗效果的影响]

[Activity of the renin-angiotensin-aldosterone system and its impact on the effectiveness of treatment of chronic heart failure in patients with pulmonary tuberculosis].

作者信息

Radzevich A E, Ditiatkov A E, Tikhonov V A

出版信息

Probl Tuberk. 2001(5):16-9.

PMID:11588951
Abstract

The renin-angiotension-aldosterone system (RAAS) was studied in 93 patients with pulmonary tuberculosis complicated by chronic heart failure (CHF). Radioimmunoassay was used to determine plasma renin activity (PRA) and serum angiotensin I and aldesterone levels. There was higher RAAS activity, as shown by elevated PRA. RAAS activity decreased during CHF treatment with angiotension-converting enzyme inhibitors (captopril, ramipril, prestarium) and an angiotensin II-receptor blocker (cosaar), which is indicative of the efficiency of CHF treatment.

摘要

对93例合并慢性心力衰竭(CHF)的肺结核患者的肾素 - 血管紧张素 - 醛固酮系统(RAAS)进行了研究。采用放射免疫分析法测定血浆肾素活性(PRA)以及血清血管紧张素I和醛固酮水平。PRA升高表明RAAS活性较高。在用血管紧张素转换酶抑制剂(卡托普利、雷米普利、培哚普利)和血管紧张素II受体阻滞剂(氯沙坦)治疗CHF期间,RAAS活性降低,这表明CHF治疗有效。

相似文献

1
[Activity of the renin-angiotensin-aldosterone system and its impact on the effectiveness of treatment of chronic heart failure in patients with pulmonary tuberculosis].[肾素-血管紧张素-醛固酮系统的活性及其对肺结核患者慢性心力衰竭治疗效果的影响]
Probl Tuberk. 2001(5):16-9.
2
[Effects of angiotensin-converting enzyme inhibitors and cosaar on quality of life of patients with pulmonary tuberculosis and chronic heart failure].[血管紧张素转换酶抑制剂和氯沙坦对肺结核合并慢性心力衰竭患者生活质量的影响]
Probl Tuberk. 2001(8):37-9.
3
Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.尽管使用了血管紧张素转换酶抑制剂,但严重慢性心力衰竭患者血管紧张素II水平升高的决定因素。
Int J Cardiol. 2006 Jan 26;106(3):367-72. doi: 10.1016/j.ijcard.2005.02.016.
4
Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.尾加压素2联合血管紧张素转换酶抑制剂治疗实验性心力衰竭
Clin Sci (Lond). 2008 May;114(10):635-42. doi: 10.1042/CS20070364.
5
Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure.新型口服活性肾素抑制剂阿利吉仑在慢性心力衰竭中的神经体液效应。
Eur J Heart Fail. 2007 Nov;9(11):1120-7. doi: 10.1016/j.ejheart.2007.09.002. Epub 2007 Oct 18.
6
[Activity of renin-angiotensin-aldosterone system (RAAS) and vasopressin level in patients with primary pulmonary hypertension].[原发性肺动脉高压患者肾素-血管紧张素-醛固酮系统(RAAS)活性及血管加压素水平]
Ter Arkh. 1998;70(4):33-6.
7
Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need?肾与心脏疾病中肾素-血管紧张素-醛固酮系统的阻断:我们需要阻断到何种程度?
Acta Med Indones. 2008 Jan;40(1):34-7.
8
[Activation of the renin-angiotensin-aldosterone system in heart failure].
Ital Heart J. 2005 May;6 Suppl 1:16S-23S.
9
Neurohormonal reactivation in heart failure patients on chronic ACE inhibitor therapy: a longitudinal study.慢性血管紧张素转换酶抑制剂治疗心力衰竭患者中的神经激素再激活:一项纵向研究。
Eur J Heart Fail. 1999 Dec;1(4):401-6. doi: 10.1016/s1388-9842(99)00046-x.
10
Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact.慢性心力衰竭中肾素-血管紧张素-醛固酮系统的抑制:药物选择及临床影响
Cardiol Rev. 2006 Mar-Apr;14(2):81-7. doi: 10.1097/01.crd.0000201550.94389.50.